Conference Coverage

The findings add to a growing body of research showing that it’s other co-morbidities, not HIV, that lead to worse health outcomes from COVID-19—at least among individuals who are on stable antiretroviral therapy.

For some clients, escalation is how they communicate that they feel unsafe or feel that their needs are not being taken seriously.

Multiple U.S. health agencies have released HIV-specific information, and research on HIV and the novel coronavirus is trickling in. Here's what health care providers need to know.

In addition to scientific advances, the 23rd International AIDS Conference also focused on the human rights of marginalized groups.

COVID-19 or no, there was still plenty to learn at this year's virtual conference, including for U.S. clinicians seeking to improve the care and treatment they provide to their patients living with HIV.

A pair of presentations at AIDS 2020 provides some of the largest studies to date on COVID-19 among people with HIV, but leaves us with many questions about the interplay between the two viruses.

A Chicago survey of people over 60 finds high self-reported viral suppression rates—but also clear signs that people need help navigating a range of other physical and mental health concerns.

A CROI 2020 roundup of studies on birth control and women living with HIV.

New data shows the drug is not more likely to cause birth defects.

Treating newborns with antiretroviral therapy in the hours after birth may help put HIV into remission.